Test Identifies Ovarian Cancer

OCTOBER 01, 2004

John Hopkins researchers have developed a test to detect ovarian cancer by identifying 3 proteins found in the blood of women with the disease, according to an article reported in Cancer Research (August 15, 2004). Earlier studies with the test suggested that there is a molecular signature exclusive to ovarian cancer, which can remain undetected and spread quickly.

"By identifying a select group of biomarkers specific to ovarian cancer, we not only know the proteins we are dealing with, but we can trace them back to alterations in the genetic code of ovarian cancer cells," said Daniel W. Chan, PhD, director of Biomarker Discovery Center at Johns Hopkins.

Additional studies are needed, however, before the test is commercially available for screening ovarian cancer. Chan pointed out that no blood test will be able to correctly diagnose 100% of cancerous tumors all the time.



SHARE THIS SHARE THIS
0
 

CROI 2017: Daily Oral PrEP Effective Even in Presence of Bacterial Vaginosis

Women with abnormal vaginal microbiota showed no difference in efficacy of daily oral PrEP compared to women with normal vaginal microbiota.


 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.